We are live on
!
Find out more
HI
HBK Investments Portfolio holdings
AUM
$9.85B
1-Year Est. Return
55.6%
This Fund
S&P 500
This Quarter
Est. Return
+17.33%
1 Year Est. Return
+55.6%
3 Year Est. Return
+156.38%
5 Year Est. Return
+423.64%
10 Year Est. Return
+2,347.17%
AUM
$10.4B
AUM Growth
+$2.53B
(+32%)
Cap. Flow
+$1.31B
Cap. Flow
% of AUM
12.67%
Top 10 Holdings %
Top 10 Hldgs %
59.14%
Holding
804
New
199
Increased
164
Reduced
169
Closed
151
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CZR
Caesars Entertainment Corporation
CZR
|
+$367M |
| 2 |
MDCO
Medicines Co
MDCO
|
+$259M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$109M |
| 4 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$86.7M |
| 5 |
TIF
Tiffany & Co.
TIF
|
+$71.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.57B |
| 2 |
Petrobras Class A
PBR.A
|
+$103M |
| 3 |
Takeda Pharmaceutical
TAK
|
+$45.4M |
| 4 |
LSXMA
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
|
+$25.2M |
| 5 |
LSXMK
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
|
+$23.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6% |
| 2 | Consumer Discretionary | 5.59% |
| 3 | Financials | 2.1% |
| 4 | Communication Services | 0.8% |
| 5 | Healthcare | 0.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Hyliion Holdings
HYLN
$690M
| $4M | 0.04% |
400,000
| – | – |
|
302
CALL
3M
MMM
$94.3B
| $3.97M | 0.04% |
26,910
-3,349
| -11% | -$469K |
|
303
PUT
Precigen
PGEN
$2.59B
| $3.96M | 0.04% |
722,400
| – | – |
|
304
PUT
Intel
INTC
$513B
| $3.93M | 0.04% |
65,600
-69,500
| -51% | -$3.89M |
|
305
CALL
Under Armour
UAA
$2.6B
| $3.91M | 0.04% |
181,200
-43,400
| -19% | -$843K |
|
|
306
PUT
Under Armour
UAA
$2.6B
| $3.91M | 0.04% |
181,200
-43,400
| -19% | -$843K |
|
307
Amgen
AMGN
$222B
| $3.87M | 0.04% |
16,033
-623
| -4% | -$137K |
|
308
CALL
General Dynamics
GD
$106B
| $3.86M | 0.04% |
21,900
-12,400
| -36% | -$2.23M |
|
|
AGN
309
CALL
DELISTED
Allergan plc
AGN
| $3.82M | 0.04% |
20,000
-17,200
| -46% | -$3.1M |
|
|
RARX
310
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $3.82M | 0.04% |
+81,365
| New | +$3.6M |
|
|
DISH
311
DELISTED
DISH Network Corp.
DISH
| $3.8M | 0.04% |
107,227
+43,471
| +68% | +$1.51M |
|
312
CALL
Applied Materials
AMAT
$428B
| $3.8M | 0.04% |
+62,200
| New | +$3.5M |
|
|
313
PUT
Applied Materials
AMAT
$428B
| $3.8M | 0.04% |
+62,200
| New | +$3.5M |
|
314
The RealReal
REAL
$1.5B
| $3.77M | 0.04% |
200,000
| – | – |
|
315
CALL
PayPal
PYPL
$50.5B
| $3.72M | 0.04% |
34,400
-22,300
| -39% | -$2.32M |
|
|
316
PUT
PayPal
PYPL
$50.5B
| $3.72M | 0.04% |
34,400
-22,300
| -39% | -$2.32M |
|
317
CALL
Nike
NKE
$61.9B
| $3.72M | 0.04% |
36,700
+25,700
| +234% | +$2.42M |
|
318
Humana
HUM
$46.2B
| $3.65M | 0.04% |
9,972
+6,130
| +160% | +$1.94M |
|
319
Walmart Inc
WMT
$890B
| $3.63M | 0.04% |
91,683
+603
| +0.7% | +$23.9K |
|
320
PUT
Procter & Gamble
PG
$339B
| $3.62M | 0.04% |
29,000
-99,900
| -78% | -$12.2M |
|
|
ARR
321
PUT
Armour Residential REIT
ARR
$2.36B
| $3.57M | 0.03% |
40,000
| – | – |
|
322
Qorvo
QRVO
$8.74B
| $3.54M | 0.03% |
30,440
+26,127
| +606% | +$2.53M |
|
323
CALL
Valero Energy
VLO
$85.9B
| $3.52M | 0.03% |
37,600
-15,900
| -30% | -$1.5M |
|
324
CALL
Pfizer
PFE
$153B
| $3.49M | 0.03% |
93,806
-9,064
| -9% | -$323K |
|
325
PUT
Bank of America
BAC
$442B
| $3.48M | 0.03% |
+98,800
| New | +$3.19M |
|
Similar funds
MF
MPI
URS
CCM
HRCM
FCM
HL
DCP
HBK Investments's Q4 2019 Portfolio in Review
As of Q4 2019, HBK Investments held 804 positions worth $10.4B, up 32% from $7.82B the previous quarter. Its ten largest holdings account for 59% of the portfolio.
HBK Investments deployed $1.31B of net new capital in Q4 2019, opening 199 new positions and adding to 164 existing holdings. Its largest new stake was Medicines Co: 3,880,000 shares worth $330M.
By sector, the portfolio is most concentrated in Technology at 6% of assets, down from 6.8% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Liberty Media Corporation Series A Liberty SiriusXM Common Stock, an estimated $25.2M trimmed.
- HBK Investments's largest Q4 2019 buy was Medicines Co: 3,880,000 shares worth $330M.
- HBK Investments added most to Caesars Entertainment Corporation in Q4 2019, an estimated $367M increase.
- HBK Investments's biggest Q4 2019 reduction was Liberty Media Corporation Series A Liberty SiriusXM Common Stock, cutting an estimated $25.2M.
- HBK Investments fully exited Celgene Corp in Q4 2019, selling an estimated $1.57B.
- HBK Investments's ten largest holdings make up 59% of its $10.4B portfolio in Q4 2019.
- HBK Investments opened 199 new positions and closed 151 in Q4 2019.
- HBK Investments's portfolio value rose 32% quarter-over-quarter to $10.4B.
Based on HBK Investments's 13F filing for Q4 2019, filed 14 Feb 2020.